Annie‐Claude Benichou

Safety and Efficacy of Subcutaneous-Administered Omacetaxine Mepesuccinate in Imatinib-Resistant Chronic Myeloid Leukemia (CML) Patients Who Harbor the Bcr- Abl T315I Mutation–Results of An Ongoing Multicenter Phase 2/3 Study.

Jörge E. Cortes, H. Jean Khoury, Franck E. Nicolini et al. · Blood · 2009 · 40 citations

Safety and Efficacy of Subcutaneous-Administered Omacetaxine Mepesuccinate in Chronic Myeloid Leukemia (CML) Patients Who Are Resistant or Intolerant to Two or More Tyrosine Kinase Inhibitors – Results of A Multicenter Phase 2/3 Study.

Jörge E. Cortes, Raghunadharao Digumarti, Purvish Parikh et al. · Blood · 2009 · 32 citations

Safety and Efficacy of Subcutaneous (SC) Omacetaxine Mepesuccinate in Imatinib(IM)-Resistant Chronic Myeloid Leukemia (CML) Patients (pts) with the T315I Mutation – Results of An Ongoing Multicenter Phase II Study.

Jörge E. Cortes, H. Jean Khoury, Sélim Corm et al. · Blood · 2008 · 15 citations

A proprietary blend of quail egg for the attenuation of nasal provocation with a standardized allergenic challenge: a randomized, double‐blind, placebo‐controlled study

Annie‐Claude Benichou, Marion Armanet, Anthony Bussière et al. · Food Science & Nutrition · 2014 · 13 citations · Full text

First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management

Laurence Moss, Cécile L. Berends, Emilie M.J. van Brummelen et al. · British Journal of Clinical Pharmacology · 2021 · 13 citations · Full text